Skip to main content

Guidance for health boards, trusts and other stakeholders on how to follow NICE guidelines.

First published:
8 June 2020
Last updated:

Overview

We are working with the National Institute for Health and Care Excellence (NICE) to improve quality in health and social care.

All NICE guidelines apply to Wales and are subject to Welsh legislation.

These can be:

  • clinical
  • social care
  • public health
  • medicines practice
  • cancer services
  • antimicrobial prescribing

TAGs must be made available within 60 calendar days after the first publication of the Final Appraisal Determination (FAD). We provide a New Treatment Fund to help health boards and trusts achieve this. 

What Health Boards, Trusts and Local Authorities should do to make best use of NICE guidance and quality standards

To help us improve services and support our long term plan, we expect health boards, local authorities and trusts to:

  • sign up as stakeholders and comment on developing guidelines
  • develop systems and processes for disseminating, implementing and risk assessing against NICE guidelines and quality standards
  • identify any gaps and action required to improve the quality of services
  • provide assurance to Welsh Government that NICE guidelines have been considered, if requested
  • ensure that new medicines recommended are available within 60 calendar days of the FAD
  • report the time it takes to place medicines recommended by NICE TAGs on prescribing lists

NICE has appointed an implementation facilitator who is based in Wales to engage with key partner organisations. They will support teams in Wales to make the best use of NICE products to deliver high-quality services. Contact NICEfieldteam@nice.org.uk for further information.

Share this page